Search Clinical Trials
596,159 trials
ID
Status
Phase
Title
Sponsor
NCT07737106
Phase I/II Clinical Trial of Influenza Vaccine (Split Virion), Inactivated (High Dose)Sinovac Biotech Co., LtdCompletedPhase 1
NCT07737106Completed
Phase 1
Phase I/II Clinical Trial of Influenza Vaccine (Split Virion), Inactivated (High...Sinovac Biotech Co., Ltd
NCT07736937
Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian CancerTubulis GmbHRecruitingPhase 1
NCT07736937Recruiting
Phase 1
Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-...Tubulis GmbH
NCT07735572
Effectiveness of an Arabic CPIC-Based Pharmacogenomics Microlearning Program on Community Pharmacists' Clinical Decision-Making in JordanUniversity of PetraCompletedNot Applicable
NCT07735572Completed
Not Applicable
Effectiveness of an Arabic CPIC-Based Pharmacogenomics Microlearning Program on...University of Petra
NCT07737704
Assessment of a New Enhanced Xenograft in Open Maxillary Sinus AugmentationMisr International UniversityRecruitingPhase 2
NCT07737704Recruiting
Phase 2
Assessment of a New Enhanced Xenograft in Open Maxillary Sinus AugmentationMisr International Univer...
NCT07736053
Alveolar Ridge Preservation Using Acemannan Aloe Vera Versus Natural Socket HealingCairo UniversityCompletedNot Applicable
NCT07736053Completed
Not Applicable
Alveolar Ridge Preservation Using Acemannan Aloe Vera Versus Natural Socket Heal...Cairo University
NCT07736586
A Study of HL40626S Tablets in Healthy AdultsHighslab Therapeutics, Inc.Not Yet RecruitingPhase 1
NCT07736586Not Yet Recruiting
Phase 1
A Study of HL40626S Tablets in Healthy AdultsHighslab Therapeutics, In...
NCT07737119
Impact of Optimised Protein Intake on Household Work Limitations and Disability in Rheumatoid ArthritisSatguru Partap Singh HospitalsCompletedNot Applicable
NCT07737119Completed
Not Applicable
Impact of Optimised Protein Intake on Household Work Limitations and Disability...Satguru Partap Singh Hosp...
NCT07738055
Study on the Combined Treatment of Hepatocellular Carcinoma With Envafolimab, Suvemcitug and HAIC ConversionTianjin Medical University Cancer Institute and HospitalNot Yet RecruitingNot Applicable
NCT07738055Not Yet Recruiting
Not Applicable
Study on the Combined Treatment of Hepatocellular Carcinoma With Envafolimab, Su...Tianjin Medical Universit...
NCT07737509
Understanding the Genetic and Biological Factors That Influence Cancer Treatment Response and Resistance in Patients With Advanced Solid Tumours Through Sample AnalysisInstitute of Cancer Research, United KingdomRecruiting
NCT07737509Recruiting
—
Understanding the Genetic and Biological Factors That Influence Cancer Treatment...Institute of Cancer Resea...
NCT07737587
Yoga-Based Breathing Exercises in a Salt-Cave Environment Versus a Standard Clinical Setting in SmokersSinop UniversityCompletedNot Applicable
NCT07737587Completed
Not Applicable
Yoga-Based Breathing Exercises in a Salt-Cave Environment Versus a Standard Clin...Sinop University
NCT07736963
Discontinuation Recommendations for GLP-1 Receptor Agonists Prior to Colonoscopy: A Randomized Controlled Trial in Taiwan.Fu Jen Catholic University HospitalRecruitingNot Applicable
NCT07736963Recruiting
Not Applicable
Discontinuation Recommendations for GLP-1 Receptor Agonists Prior to Colonoscopy...Fu Jen Catholic Universit...
NCT07736781
Research Title: Long Term Functional Outcome of a Single Hyaluronic Acid Injection in Improving Symptoms and Function in Patients With Knee Osteoarthritis - A Single-Arm Open-Label Study (DIART ONE).Hospital Universiti Sains MalaysiaNot Yet RecruitingPhase 3
NCT07736781Not Yet Recruiting
Phase 3
Research Title: Long Term Functional Outcome of a Single Hyaluronic Acid Injecti...Hospital Universiti Sains...
NCT07738029
OBE2026 - Effect of One Year Intensive Lifestyle Treatment in Children With ISO-BMI Over 30kg/m² and Their Families.Tampere University HospitalRecruitingNot Applicable
NCT07738029Recruiting
Not Applicable
OBE2026 - Effect of One Year Intensive Lifestyle Treatment in Children With ISO-...Tampere University Hospit...
NCT07735637
A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).AstraZenecaNot Yet RecruitingPhase 3
NCT07735637Not Yet Recruiting
Phase 3
A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120...AstraZeneca
NCT07737249
Efficacy and Safety of Golidocitinib for Rapidly Progressive Interstitial Lung DiseasePeking Union Medical College HospitalNot Yet RecruitingPhase 2
NCT07737249Not Yet Recruiting
Phase 2
Efficacy and Safety of Golidocitinib for Rapidly Progressive Interstitial Lung D...Peking Union Medical Coll...
NCT07737561
Blood Pressure Response to Exercise and Aortic Stiffness in Patients With Cardiovascular-Kidney-Metabolic SyndromeKaramanoğlu Mehmetbey UniversityRecruiting
NCT07737561Recruiting
—
Blood Pressure Response to Exercise and Aortic Stiffness in Patients With Cardio...Karamanoğlu Mehmetbey Uni...
NCT07737652
Microcurrent Neurofeedback as an Adjunct to Standard Care for Substance Use DisordersUniversity of Alabama, TuscaloosaCompletedNot Applicable
NCT07737652Completed
Not Applicable
Microcurrent Neurofeedback as an Adjunct to Standard Care for Substance Use Diso...University of Alabama, Tu...
NCT07736092
Perioperative Transcranial Photobiomodulation and Delayed Neurocognitive Recovery in Older PatientsPeking University First HospitalNot Yet RecruitingNot Applicable
NCT07736092Not Yet Recruiting
Not Applicable
Perioperative Transcranial Photobiomodulation and Delayed Neurocognitive Recover...Peking University First H...
NCT07736677
Digital Intraosseous Anesthesia in MIH-Affected Permanent MolarsEge UniversityCompletedNot Applicable
NCT07736677Completed
Not Applicable
Digital Intraosseous Anesthesia in MIH-Affected Permanent MolarsEge University
Result Breakdown
Completed8 (40%)
Recruiting6 (30%)
Not yet recruiting6 (30%)
not_applicable11 (55%)
Phase 13 (15%)
Phase 22 (10%)
Not Specified2 (10%)
Phase 32 (10%)